Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1762-1770

  Pfaller, Michael A ^a   Jones, Ronald N ^a   Doern, Gary V ^a   Kugler, Kari ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; GENTAMICIN; IMIPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINUPRISTIN; RIFAMPICIN; SPARFLOXACIN; STREPTOMYCIN; TAZOBACTAM; TEICOPLANIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; IMMUNOSURVEILLANCE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 0031862259     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1762     Document Type: Article

References (22)

1. Archibald, L., L. Phillips, D. Monnet, J. E. McGowan, Jr., F. Tenover, and R. Gaynes. 1997. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin. Infect. Dis. 24:211-215.
2. Ballow, C. H., and J. J. Schentag. 1992. Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group. Diagn. Microbiol. Infect. Dis. 15:37S-42S.
3. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edwards, J. Toison, T. Henderson, and W. J. Martone. 1991. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am. J. Med. 91(Suppl. 3B):86S-89S.
4. Emori, T. G., D. H. Culver, and T. C. Horan. 1991. National Nosocomial Infections Surveillance (NNIS) system: description of surveillance methods. Am. J. Infect. Control 19:19-35.
5. Emori, T. G., and R. P. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6: 428-442.
6. Jarvis, W. R., J. R. Edwards, D. H. Culver, J. M. Hughes, T. C. Horan, T. G. Emori, S. N. Banerjee, J. S. Tolson, T. S. Henderson, R. P. Gaynes, and W. J. Martone. 1991. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am. J. Med. 91(Suppl. 3B):185S-191S.
7. Jarvis, W. R., and W. J. Marton. 1992. Predominant pathogens in hospital infections. J. Antimicrob. Chemother. 29(Suppl. A):19-24.
8. Jones, R. N. 1996. The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Diagn. Microbiol. Infect. Dis. 25:1-9.
9. Jones, R. N., E. N. Kehrberg, M. E. Erwin, S. C. Anderson, and the Fluoroquinolone Resistance Surveillance Group. 1994. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. I. Study on the threat of emerging resistances: real or perceived? Diagn. Microbiol. Infect. Dis. 19:203-215.
10. Jones, R. N., S. A. Marshall, M. A. Pfaller, W. W. Wilke, R. J. Hollis, M. E. Erwin, M. B. Edmond, R. P. Wenzel, and the SCOPE Hospital Study Group. 1997. Nosocomial enterococcal bloodstream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. Diagn. Microbiol. Infect. Dis. 29:95-102.
11. Marshall, S. A., W. W. Wilke, M. A. Pfaller, and R. N. Jones. 1998. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mec A) characterization of oxacillin resistance in the SCOPE Program. Diagn. Microbiol. Infect. Dis. 30:205-214.
12. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1995. Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
13. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Osterholm, M. T., and K. L. MacDonald. 1995. Antibiotic-resistant bugs: when, where, and why? Infect. Control Hosp. Epidemiol. 16:382-384.
16. Paul, S. M., L. Finelli, G. L. Crane, and K. C. Spitalny. 1995. A statewide surveillance system for antimicrobial-resistant bacteria: New Jersey. Infect. Control Hosp. Epidemiol. 16:385-390.
17. Pfaller, M. A., R. N. Jones, S. A. Marshall, S. L. Coffman, R. J. Hollis, M. B. Edmond, and R. P. Wenzel. 1997. Inducible Amp C β-lactamase producing Gram-negative bacilli from bloodstream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn. Microbiol. Infect. Dis. 28:211-219.
18. Pinner, R. W., S. M. Teutseh, L. Simonsen, L. A. Klug, J. M. Graber, M. J. Clarke, and R. L. Berkelman. 1996. Trends in infectious disease mortality in the United States. JAMA 275:189-193.
19. Pittet, D., N. Li, R. F. Woolson, and R. P. Wenzel. 1997. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin. Infect. Dis. 24:1068-1078.
20. Reimer, L. G., M. L. Wilson, and M. P. Weinstein. 1997. Update on detection of bacteremia and fungemia. Clin. Microbiol. Rev. 10:444-465.
21. Voelker, R. 1996. New group tracks hospital's drug-resistant bugs. JAMA 275:177-178.
22. Weinstein, M. P., M. L. Towns, S. M. Quartey, S. Mirrett, L. G. Reimer, G. Parmigiani, and L. B. Reller. 1997. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24:584-602.